Etomidate is one of the anaesthetic induction agents which has gained popularity for its minimal cardiovascular and respiratory depressant effects when compared with other agents. It does not appear to release histamine. ~-3 It decreases cerebral metabolic rate, cerebral blood flow, and intracranial pressure. These characteristics are beneficial in neurosurgical procedures. 4'5 Evoked potentials (EPs), which are used in monitoring the integrity of the nervous system during various operations, are frequently affected by anaesthetic agents. In spite of their vulnerability to various factors during surgery, visual evoked potentials (VEP) have been used to monitor the integrity of the visual pathways during neurosurgical procedures 6"7 and the function of the central nervous system during cardiopulmonary bypass since disturbance of visual function is one of the most common complications following cardiovascular surgery.s-Io A VEF is elicited by flashes from light-emitting diodes attached to a pair of goggles which are placed over the patient's closed eyes. Several positive and negative peaks are observed at various times after the stimuli. Some frequently recognized peaks are P60, N70, and PI00. Of these, PI00 is relatively stable and the most useful clinically. Other peaks are more vulnerable and have too much variation to be considered clinically important. The PI00, which is observed at approximately 100 msec after the stimuli, is thought to arise in the striated and parastriated visual cortex. ~1 The origins of the other peaks are not known.
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Since the effects of etomidate on visual evoked potentials are not known, we decided to investigate the CAN J ANAESTH 1990/ 37:4 /pp452-6 Nicolet Pathfinder I (Nicolet Biomedical Instruments, Madison, WI) was used to record the VEP. *The 10-20 international system of electrode placement was used 13. effects of etomidate on VEPs in humans. We also investigated how etomidate modified the VEP changes induced by fentanyl-nitrous oxide anaesthesia, which usually causes only a slight increase in the latency without affecting the amplitude of the VEPs. t2
Methods
This study was approved by our Institutional Review Board. Twenty-two consenting patients undergoing gynaecological procedures were studied. They were divided into two groups: the etomidate group ( 12 patients) and the fentanyI-N20-etomidate group (ten patients). The mean age and mean weight in the etomidate group were 30.7 --+ 5.2 (yr --+ SD) and 63.0 --+ 7.7 (kg --+ SD) respectively. In the fentanyl-N:O group, they were 33.0 • 4.6 (yr ---SD) and 69.3 ---13.2 (kg _ SD) respectively. None of the patients in either group had significant neurological or ophthalmological disorders. No patient received premedications. In the operating room, goggles equipped with LED were applied over the patient's closed eyes. The recording variables are described in Table 1 . ~3 Blood pressure was monitored with a Dinamap automatic blood pressure measuring device, while the ECG was monitored continuously. A Nellcor pulse oximeter sensor was applied on the index finger in order to monitor continuously arterial oxygen saturation. A Stat-Temp temperature sensor was applied on the patient's forehead. End-tidal carbon dioxide was monitored with a SARA Cap Plus multiple gas analyzer. Prior to induction of anaesthesia, the first VEP was recorded as a control.
In the etomidate group, vecuronium I mg was given as pretreatment. Then, anaesthesia was induced with a bolus injection of etomidate 0.3 mg.kg -j , which was followed by a continuous infusion of etomidate 0.05 mg.kg -~. min-i. Immediately after the bolus injection, vecuronium 0.12 mg" kg -~ was administered to diminish any visible myoclonic movements. During induction, the lungs were manually ventilated with a mask to maintain end-tidal CO2 within 35-40 mmHg. Ten seconds after the bolus injection, a recording of the VEP was started. One VEP recording was performed every minute for three minutes. Etomidate infusion was continued during VEP recordings. Tracheal intubation was delayed until VEP recordings were completed.
in the fentanyI-N20-etomidate group, anaesthesia was induced with 3-4 mg.kg -~ of thiopentone and 0.12 mg.kg -t of vecuronium. After tracheal intubation, fentanyl 3-4 ~g.kg -I and 60 per cent N20 were administered. No additional fentanyl was given until the VEP recordings were completed. Fifteen minutes after induction, a baseline VEP was recorded which was followed by the administration of a bolus injection of etomidate 0.3 mg.kg -~. Ten seconds after the etomidate administration, VEP recordings were started and the first recording was completed in approximately one minute. Subsequent recordings were performed at two, four and six minutes after the etomidate administration. Skin incision was delayed until the VEP recordings were completed.
From the VEP recordings, the first prominent positive, the first prominent negative, and the second prominent positive peaks were identified. These were designated P60, N70, and PI00, respectively. Latencies of P60, N70, and PI00 were measured. The amplitude of N70 was measured as the vertical distance between the peaks of P60 and N70, while the amplitude of PI00 was measured as the vertical distance between the peaks of N70 and PI00.
For data analysis, analysis of variance with repeated measures and the Student-Newman-Keuls multiple comparison test were performed. A P value <0.05 was considered statistically significant.
Results
Blood pressure and heart rate were stable during the study period. Satisfactory VEP recordings were obtained from all the patients studied. However, in two patients in each group, there was no recognizable P60, and they were excluded from the statistical analysis involving P60.
In the etomidate group, administration of etomidate increased the latencies of P60, N70, and PI00 slightly at various time points. On the other hand, the amplitudes of N70 (P60-N70) and PI00 (N70-PI00) were not changed significantly (Table 1I) . A typical VEP recording during induction of anaesthesia from a patient in the etomidate group is shown in Figure 1 .
In the fentanyI-N20-etomidate group, the latencies of P60, N70, and PI00 were significantly increased after the administration of fentanyl and nitrous oxide. The amplitudes showed no statistically significant changes. Administration of etomidate during fentanyi-N20 anaesthesia further increased the latencies of P60 and N70 significantly at every time point. However, the latency of PI00 showed no statistically significant increase. The amplitude of PI00 (N70-PI00) was significantly decreased after the etomidate administration. Even though it was statistically insignificant, the amplitude of NT0 (P60-NT0) seemed to increase (Table III) . A typical VEP recording after the etomidate administration from a patient in the fentanyI-N20-etomidate group is shown in Figure 2 . In our study, the temperature was maintained within a narrow range. Since CO2 tension may affect EPs, ventilation was controlled to keep the end-tidal CO2 within the normal range. 16 Premedication was eliminated. During our study, blood pressure was stable and no intervention was needed, t7 In order to eliminate the effects of surgical stimuli, all VEP recordings were performed before surgical incisions were made. ~8 In our study, induction of anaesthesia with etomidate by itself did not signficantly affect the amplitude of P I00. This is in contrast to the marked increase of the cortical SSEP found by other researchers. Several authors noted that 0.3-0.4 mg. kg-~ of etomidate given intravenously markedly increased the amplitude of N20-P23 in the cortical portion of the somatosensory evoked potentials (SSEP) in humans.tg'2~ The latencies of N20 and P23 were only slightly increased. Ebner et al. also found that the amplitudes of the parietal P25 and the frontal N30 of the SSEP were markedly increased by the intravenous administration of etomidate. 2t These findings were similar to those observed in patients with conical myoclonus who did not receive any anaesthesia. They suggested that there was a separation of relatively stable (P14, N20, P22) and modifiable (P25, N30) components of the SSEP in the sensory motor cortex. These modifiable components were characterized by their enhancement in conditions of cortical myoclonus and during etomidate administration in neurologically normal patients. They were abolished during the ictal period which was provoked by an electroconvulsive shock. It was speculated that a similar neurophysiological mechanism could be responsible for the alteration of the SSEP during etomidate administration and during myoclonic movements. Halliday compared SSEP and VEP in a large series of patients with progressive myoclonic epilepsy. 22 He noted large SSEP appearing in the contralateral Rolandic area. Measurement of VEP revealed large early (50-60 msec) components. The degree of enhancement of the amplitudes was much greater in SSEP (4.53 times of the control) than in VEP (I.69 times of the control). Our study also suggests that etomidate has less effects on VEP than cortical SSEP. In our study, the amplitude of N70 (P60-N70) tended to increase after administration of etomidate in both groups even though these changes were statistically not significant. This finding may be a resemblance to the enhancement of early components of the VEP in myoclonic epilepsy in Halliday's study. 22 The origin and significance of the P60 and N70 of the VEP are not known. These components of the VEP exhibit much variation and are difficult to interpret. Further exploration will be needed in order to establish a meaningful interpretation of the P60 and N70.
Discussion
Administration of etomidate during fentanyl-N20 anaesthesia did not increase the amplitude of PI00. Rather, it was decreased after the etomidate injection. This is in contrast to the findings of Sloan et al. who showed that the amplitude of the cortical SSEP was increased when etomidate was added to alfentanil-midazolam anaesthesia. 23 Further, they suggested that enhanced SSEP with etomidate might be useful in interpreting changes of EPs caused by surgical manipulation. Our findings from the fentanyI-N20-etomidate group are very similar to those of Thornton. He found that etomidate, when added to 70 per cent nitrous oxide, increased the latency and decreased the amplitude of early cortical auditory evoked potentials. 24 Obviously, the effects of etomidate on cortical evoked potentials are different from one modality of the EPs to the other.
In conclusion, interpretation of the VEP during etomidate administration alone may not be hard to perform. However, when given together with fentanyl-nitrous oxide anaesthesia, the VEP was affected significantly making its interpretation difficult.
